Akari Therapeutics PLC (AKTX)
3.16
+0.11
(+3.61%)
USD |
NASDAQ |
Jun 14, 16:00
3.16
0.00 (0.00%)
After-Hours: 20:00
Akari Therapeutics Accounts Payable (Quarterly): 3.208M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 3.208M |
June 30, 2023 | 1.031M |
June 30, 2022 | 1.635M |
March 31, 2022 | 3.076M |
December 31, 2021 | 1.789M |
September 30, 2021 | 1.923M |
June 30, 2021 | 1.685M |
March 31, 2021 | 2.832M |
December 31, 2020 | 3.381M |
September 30, 2020 | 2.410M |
June 30, 2020 | 2.191M |
March 31, 2020 | 0.9661M |
December 31, 2019 | 1.229M |
September 30, 2019 | 1.315M |
June 30, 2019 | 1.482M |
March 31, 2019 | 1.763M |
December 31, 2018 | 1.586M |
Date | Value |
---|---|
September 30, 2018 | 1.404M |
June 30, 2018 | 2.002M |
March 31, 2018 | 2.384M |
December 31, 2017 | 1.971M |
September 30, 2017 | 1.943M |
June 30, 2017 | 2.842M |
March 31, 2017 | 0.9245M |
December 31, 2016 | 2.214M |
September 30, 2016 | 1.308M |
June 30, 2016 | 1.918M |
March 31, 2016 | 0.6254M |
December 31, 2015 | 4.321M |
September 30, 2015 | 3.754M |
June 30, 2015 | 0.629M |
March 31, 2015 | 0.296M |
December 31, 2014 | 0.5555M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.9661M
Minimum
Mar 2020
3.381M
Maximum
Dec 2020
2.010M
Average
1.789M
Median
Dec 2021
Accounts Payable (Quarterly) Benchmarks
DBV Technologies SA | 18.08M |
Cellectis SA | 16.05M |
Adaptimmune Therapeutics PLC | 6.587M |
Biodexa Pharmaceuticals Plc | 0.40M |
Verona Pharma PLC | 4.651M |